PATENT CLAIM ANALYSIS

Application Number: 16036381
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "190100"]

Abstract:
Methods and apparatus are provided for applying an fragment of a neurotoxin such as the active light chain (LC) of the botulinum toxin (BoNT), such as one of the serotype A, B, C, D, E, F or G botulinum toxins, via permeabilization of targeted cell membranes to enable translocation of the botulinum neurotoxin light chain (BoNT-LC) molecule across the targeted cell membrane to the cell cytosol where a therapeutic response is produced in a mammalian system. The methods and apparatus include use of catheter based delivery systems, non-invasive delivery systems, and transdermal delivery systems.

Claim (Index 33):
The system of  claim 30 , the system further comprising:\n a second energy emitter operably coupled to the energy generator, and coupled to the movable mechanism relative to the first energy emitter such that an arrangement of the first and second energy emitters causes the energy field produced therefrom to be concentrated in a lateral direction from the main catheter body.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.63235
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14601529', '13660629', '13253595', '12559278', '11459090']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7485812377229084
- 35 USC 102 Novelty (BERT): 0.5768940618080138
- Combined Prediction Score: 0.731412520131419
- Mean Citation Score: 396.601012
- Max Citation Score: 485.664
- Similarity Product: 385.8787161083221

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test